| Application no. and date | 11781973.0 (espacenet) (Federated) (European Patent Register), 20111103 | | Patent/reg. no. and date | DK/EP 2635677, 20200101 | | Publication date | 20130911 | | Priority no. and date | US 456298 P, 20101103 | | EP pub. no. and date |
EP 2635677 20130911 | | Effective date | | | Applicant/owner | GC BIOPHARMA CORP., 107, Ihyeon-Ro 30Beon-Gil
Giheung-gu, Yongin-Si
16924 Gyeonggi-Do, KR | | Applicant ref. no. | 6.2003.004 | | Inventor | MADISON, Edwin, L., 558 48th Avenue
San Francisco
CA 94121, US,
THANOS, Christopher, 38 Meadow Hill Drive
Tiburon
CA 94920, US,
BLOUSE, Grant, Ellsworth, Thingvalla Alle 41, 2300 København S, DK | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | C12N 9/64 (2006.01) | | Title | Modificeret faktor IX-polypeptider og anvendelser deraf | | Int. application no. | US2011059233 | | Int. publication no. | WO2012061654 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
